Addus HomeCare Co. (NASDAQ:ADUS) Shares Acquired by DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main

DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 77.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,836 shares of the company's stock after buying an additional 3,862 shares during the quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main's holdings in Addus HomeCare were worth $1,108,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the stock. EP Wealth Advisors LLC boosted its position in Addus HomeCare by 17.8% during the fourth quarter. EP Wealth Advisors LLC now owns 2,202 shares of the company's stock worth $276,000 after purchasing an additional 332 shares in the last quarter. Cetera Investment Advisers raised its holdings in shares of Addus HomeCare by 89.8% during the fourth quarter. Cetera Investment Advisers now owns 3,981 shares of the company's stock valued at $499,000 after acquiring an additional 1,884 shares during the last quarter. BOKF NA raised its holdings in shares of Addus HomeCare by 7.3% during the fourth quarter. BOKF NA now owns 4,108 shares of the company's stock valued at $515,000 after acquiring an additional 280 shares during the last quarter. Bank of America Corp DE raised its holdings in shares of Addus HomeCare by 273.6% during the fourth quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock valued at $21,945,000 after acquiring an additional 128,211 shares during the last quarter. Finally, Lido Advisors LLC raised its holdings in shares of Addus HomeCare by 60.7% during the fourth quarter. Lido Advisors LLC now owns 2,671 shares of the company's stock valued at $335,000 after acquiring an additional 1,009 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company's stock.

Addus HomeCare Stock Up 1.6%

NASDAQ:ADUS traded up $1.73 on Friday, reaching $111.63. The company's stock had a trading volume of 158,285 shares, compared to its average volume of 165,612. Addus HomeCare Co. has a 12-month low of $88.96 and a 12-month high of $136.72. The firm has a market cap of $2.05 billion, a price-to-earnings ratio of 25.54, a price-to-earnings-growth ratio of 1.41 and a beta of 0.85. The stock has a 50 day moving average price of $100.30 and a 200 day moving average price of $113.74.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, beating analysts' consensus estimates of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $337.71 million for the quarter, compared to the consensus estimate of $341.66 million. During the same quarter in the previous year, the business earned $1.21 earnings per share. The company's revenue for the quarter was up 20.3% on a year-over-year basis. Equities research analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ADUS has been the subject of a number of research analyst reports. Stephens reissued an "overweight" rating and set a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. JMP Securities reaffirmed a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a report on Tuesday, April 22nd. Oppenheimer increased their price target on Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. StockNews.com cut Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Finally, Macquarie increased their price target on Addus HomeCare from $129.00 to $133.00 and gave the company an "outperform" rating in a report on Thursday, May 8th. One investment analyst has rated the stock with a hold rating, six have given a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Buy" and an average target price of $142.57.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.